Navigation Links
A drug in vogue to deccelerate the course of Alzheimer's

Alzheimer’s disease continues to fuel research, as the incidence is likely to increase in the future. A new drug has been developed to slow the course of Alzheimer's disease. There is a special chemical called glutamate, which is one of the brain’s messenger and this chemical//is regulated by a drug called Memantine. Learning and memory are the fields, which are enabled by the chemical glutamate. This happens when glutamate is in its normal concentration. Its concentration can increase or decrease according to the level of Alzheimer's disease.

Available treatments for Alzheimer's that have proven effective at treating mild to moderate stages of the disease are aimed at a different chemical system in the brain, the cholinergic system. Memantine has been approved for use in Germany for more than 10 years.

The Food and Drug Administration is reviewing its safety and efficacy for possible U.S. sale of this drug. Approval could happen by this fall. Findings from a randomized, double-blind study of the drug in 252 patients were published in the April 3 New England Journal of Medicine.

Patients who took Memantine seemed to decline about half as much during the six-month trial as would ordinarily be expected, said Barry Reisberg, MD, professor of psychiatry at New York University School of Medicine, who led the study. Another issue that must be teased out is whether antioxidants in a pill are as beneficial as those in food, noted Paula Bickford, PhD, professor of neurosurgery at the University of South Florida, Tampa.
'"/>




Page: 1

Related medicine news :

1. Sun screen in vogue: for fashion and for health!
2. Postpone intercourse after childbirth
3. Satisfied Sexual Intercourse for Impotence men with Penile Prosthesis
4. Schools set to offer Japanese language course
5. A New Study Discredits The Myth Of Sexual Intercourse Late In Pregnancy Speeds Labour & Delivery
6. Indias Law on Homosexuality Needs Recourse - Hampers HIV Prevention
7. Timing of First Intercourse is Vital
8. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
9. Decrease in testosterone levels lead to Alzheimers
10. Smokers are prone to Alzheimers
11. Over-The-Counter Drugs May Prevent Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5-star rating ... , As the stress of modern life continually makes more demands on time and ... artificial stimulants can trap people in vicious high/low cycles and can also cause long ...
(Date:8/21/2017)... ... August 22, 2017 , ... PracticeMatch, a company that provides online ... with physicians and advanced practitioners like nurse practitioners and physician assistants ... through November of this year. The online career fairs will allow job seekers to ...
(Date:8/21/2017)... ... 21, 2017 , ... Los Angeles area medical group Beverly ... year 2017-2018, Christina M. Busuito, M.D. and Lukasz Swistun, M.D. This one year ... Reconstructive Surgery. The candidate will have the opportunity to work with leading ...
(Date:8/21/2017)... California (PRWEB) , ... August 21, 2017 , ... Five ... money and awareness for Alzheimer’s Family Center. , Guests will be able to ... Newport Beach Plaza, Braised Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & ...
(Date:8/21/2017)... ... ... The experts have spoken. Prolonged sitting and standing are a no-no for ... healthy way these days? FlexiSpot, one of the fastest-growing manufacturers of ergonomic office solutions, ... Deskcise Pro™– the world’s first sit-stand-cycle desk to backers worldwide. , The Launch , ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one ... by Crain,s Detroit Business . The annual ... three-year revenue growth. This year,s edition measures growth from 2013 ... the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... said Phil Hagerman , CEO and chairman of Diplomat. ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
(Date:7/27/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: ... second-quarter 2017 and updated financial guidance for the full-year ... Highlights Reported net sales of $397.6 ... quarter. Net sales at constant currency (organic) grew by ... $0.51, compared to $0.60 in the prior-year quarter. Second-quarter ...
Breaking Medicine Technology: